Investing Profile

Alaa Halawa(1)

Investor

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
14
CompanyStageDateRound SizeTotal Raised
GC Therapeutics
Series ASep 2024$65M
$65M
Co-investors: Hiroki Takai (Global Brain)
Rejuveron Life Sciences
Series BSep 2023$75M
$75M
EpiBiologics
Series AMar 2023$73M
$96M
Co-investors: David Schenkein (GV (Google Ventures)), Alexandra Cantley (Polaris Partners), Samuel Bjork (Digitalis Ventures)
Paradigm
Series AJan 2023$200M
$240M
Co-investors: Elena Viboch (General Catalyst), Ramnik Arora (FTX Ventures), Hemant Taneja (General Catalyst), Bilal Zuberi (Lux Capital), Brett Cook (F-Prime Capital Partners), Stephen Knight (F-Prime Capital Partners), Jay Markowitz (ARCH Venture Partners), Robert Nelsen (ARCH Venture Partners), Jared Friedman (Y Combinator), Scott Belsky, Eoghan McCabe, Arash Ferdowsi
UpStream Care
Series BDec 2022$140M
$140M
Co-investors: Eric Jones (Dragoneer Investment Group), Chirag Shah (Define Ventures), Lynne Chou O’Keefe (Define Ventures), Ayman AlAbdallah
Neumora Therapeutics
Series BOct 2022$110M
$510M
Co-investors: Stacie Weninger (F-Prime Capital Partners), Robert Nelsen (ARCH Venture Partners), Kristina Burow (ARCH Venture Partners)
Alloy Therapeutics
Series DOct 2022$42M
Series CApr 2021$75M
$130M
Co-investors: Alex Kolicich (8VC), Peter Thiel (Founders Fund), Fabian Hansen (Presight Capital)
Pretzel Therapeutics
Series ASep 2022$73M
$73M
Co-investors: Per Samuelsson (HealthCap), Robert Tansley (Cambridge Innovation Capital), Jay Parrish (ARCH Venture Partners), Reetika Bhardwaj (ARCH Venture Partners), Kristina Burow (ARCH Venture Partners)